Skip to main content

Table 5 Associations between initial AMH (ng/dl) during years 1–4 and cIMT (mm) before and after adjustment for concurrent CVD risk factors

From: Anti-Müllerian hormone and its relationships with subclinical cardiovascular disease and renal disease in a longitudinal cohort study of women with type 1 diabetes

 

Unadjusted

Adjusted for age

Adjusted for age and SBP

Adjusted for age, total cholesterol, and HDL

Adjusted for age and A1c

Models for year 1 cIMTa

 AMH

0.00009 ± 0.002

0.002 ± 0.002

0.002 ± 0.002

0.002 ± 0.002

0.002 ± 0.002

 p-value

0.95

0.11

0.10

0.22

0.13

Models for year 6 cIMTb

 AMH

0.00008 ± 0.002

0.005 ± 0.002

0.005 ± 0.002

0.004 ± 0.002

0.004 ± 0.002

 p-value

0.66

0.0087

0.008

0.019

0.014

  1. aWomen who had AMH measurement at year 1 and cIMT measurements at EDIC year 1 (n = 172)
  2. bWomen who had AMH measurement at year 1 and cIMT measurements at EDIC year 6 (n = 390)
  3. Least square means and standard errors shown